UBS Group AG institutional holdings, Q4 FY2021

SEC Filing Summary: UBS Group AG (13F-HR)

Business Context and Reporting Period

This filing is a Form 13F-HR (Holdings Report) submitted by UBS Group AG, an institutional investment manager based in Zurich, Switzerland. The report covers the calendar quarter ended December 31, 2021, and was signed on February 10, 2022. The filing represents a combination report, including holdings managed by UBS Group AG and 11 other affiliated managers, such as UBS Asset Management (Americas) Inc. and UBS Securities LLC.

Key Financial Metrics

As a Form 13F filing, this document discloses equity holdings rather than the issuer's operational financial performance. Consequently, the filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity for UBS Group AG itself. The primary metric disclosed is the aggregate value of reportable securities:

  • Total Value of Reportable Securities: $349,144,051,000 (reported in thousands).
  • Total Number of Holdings Entries: 20,787.

Material Changes

The filing text provided does not contain comparative data for the prior period (September 30, 2021) or a breakdown of specific changes in holdings. Therefore, material changes in portfolio composition or value versus the prior comparable period cannot be determined from this summary page alone.

Guidance, Outlook, and Risks

Form 13F filings are regulatory disclosures of past holdings and do not contain management commentary, forward-looking guidance, outlooks, or risk factors regarding the reporting manager's business operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.

Investor Verification Checklist

  • Verify the total portfolio value of approximately $349.1 billion against the full schedule of holdings to confirm asset allocation.
  • Review the list of 11 other included managers to ensure all relevant UBS entities are accounted for in the consolidated view.
  • Note that this document does not reflect UBS Group AG's own financial health (e.g., earnings, capital ratios); refer to the company's 10-K or 20-F for operational metrics.
  • Confirm the filing date (February 10, 2022) aligns with the regulatory deadline for the Q4 2021 period.